X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (668) 668
skin-structure infections (643) 643
index medicus (513) 513
pharmacology & pharmacy (431) 431
anti-bacterial agents - therapeutic use (374) 374
infectious diseases (326) 326
microbiology (309) 309
complicated skin (272) 272
soft-tissue infections (230) 230
anti-bacterial agents - pharmacology (226) 226
resistant staphylococcus-aureus (224) 224
male (193) 193
in-vitro activity (183) 183
female (176) 176
antibiotics (167) 167
vancomycin (162) 162
anti-bacterial agents - adverse effects (156) 156
middle aged (153) 153
adult (149) 149
microbial sensitivity tests (143) 143
treatment outcome (136) 136
double-blind (132) 132
acute bacterial skin (126) 126
aged (120) 120
staphylococcus aureus (120) 120
minocycline - analogs & derivatives (119) 119
bacterial infections - drug therapy (115) 115
skin diseases, bacterial - drug therapy (111) 111
gram-positive bacterial infections - drug therapy (109) 109
anti-bacterial agents - pharmacokinetics (108) 108
efficacy (107) 107
pharmacokinetics (107) 107
staphylococcal infections - drug therapy (106) 106
methicillin-resistant staphylococcus aureus (103) 103
tigecycline (102) 102
animals (99) 99
daptomycin (99) 99
safety (99) 99
anti-bacterial agents - administration & dosage (98) 98
internal medicine (95) 95
mrsa (95) 95
health aspects (90) 90
drug therapy (89) 89
methicillin-resistant staphylococcus aureus - drug effects (89) 89
methicillin-resistant (88) 88
community-acquired pneumonia (85) 85
linezolid (82) 82
complicated intraabdominal infections (81) 81
research (80) 80
immunology (78) 78
pneumonia (78) 78
minocycline - therapeutic use (77) 77
skin (77) 77
staphylococcal infections - microbiology (77) 77
infections (75) 75
infectious disease (75) 75
care and treatment (73) 73
staphylococcus-aureus (73) 73
adolescent (72) 72
drug resistance, bacterial (68) 68
staphylococcus aureus - drug effects (68) 68
staphylococcus infections (67) 67
gram-positive bacteria - drug effects (65) 65
gram-positive bacterial infections - microbiology (65) 65
staphylococcus aureus infections (65) 65
clinical trials (64) 64
clinical trials as topic (64) 64
antimicrobial agents (63) 63
bacteremia (63) 63
aged, 80 and over (61) 61
drug resistance in microorganisms (61) 61
medicine, general & internal (61) 61
dermatology (59) 59
gram-positive infections (59) 59
united-states (59) 59
daptomycin - therapeutic use (58) 58
in-vitro (58) 58
gram-positive bacteria (57) 57
minocycline - pharmacology (57) 57
antibacterial agents (56) 56
in-vitro activities (55) 55
drug resistance, multiple, bacterial (54) 54
vancomycin - therapeutic use (54) 54
young adult (54) 54
acute bacterial skin and skin structure infections (53) 53
bacterial infections (53) 53
cephalosporins - pharmacology (53) 53
bacteria (52) 52
soft tissue infections - drug therapy (51) 51
susceptibility (51) 51
therapy (50) 50
cephalosporins - therapeutic use (49) 49
dosage and administration (49) 49
drug resistance (49) 49
resistance (49) 49
retrospective studies (49) 49
skin diseases, bacterial - microbiology (48) 48
dalbavancin (47) 47
medicine & public health (47) 47
ventilator-associated pneumonia (47) 47
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (890) 890
Spanish (22) 22
German (10) 10
French (7) 7
Italian (2) 2
Russian (2) 2
Japanese (1) 1
Portuguese (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Infectious Diseases, ISSN 1058-4838, 9/2010, Volume 51, Issue 2, pp. S183 - S197
Although first identified just >4 decades ago, methicillin-resistant Staphylococcus aureus (MRSA) has undergone rapid evolutionary changes and epidemiologic... 
Osteomyelitis | Infectious diseases | Antibiotics | Antimicrobials | Endocarditis | Abscesses | Methicillin resistant staphylococcus aureus | Infections | Staphylococcus aureus | Bacteremia | SOFT-TISSUE INFECTIONS | HEALTH-CARE SETTINGS | INFECTIOUS DISEASES | ANTIMICROBIAL THERAPY | TRANSESOPHAGEAL ECHOCARDIOGRAPHY | MICROBIOLOGY | IMMUNOLOGY | COMPLICATED SKIN | IN-VITRO | EMERGENCY-DEPARTMENT | SKIN-STRUCTURE INFECTIONS | DOUBLE-BLIND | PERIPHERAL NEUROPATHY | Community-Acquired Infections - diagnosis | Staphylococcal Infections - pathology | Humans | Osteomyelitis - drug therapy | Bacteremia - microbiology | Anti-Bacterial Agents - therapeutic use | Methicillin-Resistant Staphylococcus aureus - pathogenicity | Cross Infection - pathology | Endocarditis, Bacterial - pathology | Community-Acquired Infections - drug therapy | Osteomyelitis - pathology | Endocarditis, Bacterial - microbiology | Staphylococcal Infections - microbiology | Endocarditis, Bacterial - drug therapy | Staphylococcal Infections - drug therapy | Bacteremia - drug therapy | Endocarditis, Bacterial - diagnosis | Bacteremia - diagnosis | Cross Infection - drug therapy | Staphylococcal Infections - diagnosis | Osteomyelitis - diagnosis | Community-Acquired Infections - pathology | Osteomyelitis - microbiology | Cross Infection - microbiology | Cross Infection - diagnosis | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Bacteremia - pathology | Community-Acquired Infections - microbiology
Journal Article
International Journal of Antimicrobial Agents, ISSN 0924-8579, 04/2018, Volume 51, Issue 4, pp. 571 - 577
Dalbavancin is a lipoglycopeptide with a very prolonged half-life enabling treatment with a single intravenous administration that has been approved to treat... 
Gram-positive infection | Skin and soft-tissue infection | Dalbavancin | SOFT-TISSUE INFECTIONS | INFECTIOUS DISEASES | MANAGEMENT | ONCE-WEEKLY DALBAVANCIN | MICROBIOLOGY | RESISTANT STAPHYLOCOCCUS-AUREUS | COMPLICATED SKIN | ACUTE BACTERIAL SKIN | SKIN-STRUCTURE INFECTIONS | PARENTERAL ANTIMICROBIAL THERAPY | PHARMACOLOGY & PHARMACY | CONVENTIONAL THERAPY | CLINICAL-OUTCOMES | Humans | Middle Aged | Soft Tissue Infections - economics | Male | Teicoplanin - therapeutic use | Osteomyelitis - drug therapy | Prosthesis-Related Infections - drug therapy | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Staphylococcal Skin Infections - drug therapy | Prosthesis-Related Infections - economics | Prosthesis-Related Infections - microbiology | Enterococcus - isolation & purification | Female | Anti-Bacterial Agents - adverse effects | Retrospective Studies | Soft Tissue Infections - drug therapy | Teicoplanin - analogs & derivatives | Catheter-Related Infections - economics | Osteomyelitis - economics | Methicillin-Resistant Staphylococcus aureus - drug effects | Catheter-Related Infections - drug therapy | Spain | Teicoplanin - adverse effects | Soft Tissue Infections - microbiology | Osteomyelitis - microbiology | Catheter-Related Infections - microbiology | Cost-Benefit Analysis | Aged | Enterococcus - drug effects | Methicillin-Resistant Staphylococcus aureus - isolation & purification
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2007, Volume 56, Issue 1, pp. 1 - 16
Published data confirm that community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infections are increasing in incidence in both urban and... 
Dermatology | SOFT-TISSUE INFECTIONS | PANTON-VALENTINE LEUCOCIDIN | RISK-FACTORS | GRAM-POSITIVE INFECTIONS | SKIN-STRUCTURE INFECTIONS | INTENSIVE-CARE-UNIT | DOUBLE-BLIND TRIAL | QUINUPRISTIN-DALFOPRISTIN | INDUCIBLE CLINDAMYCIN RESISTANCE | IN-VITRO ACTIVITY | DERMATOLOGY | Recurrence | Prevalence | Community-Acquired Infections - epidemiology | HIV Infections - epidemiology | Humans | Middle Aged | Virulence | Child, Preschool | Infant | Male | Staphylococcal Skin Infections - prevention & control | Anti-Bacterial Agents - therapeutic use | Staphylococcal Skin Infections - drug therapy | Community-Acquired Infections - drug therapy | Drug Resistance, Multiple, Bacterial | Staphylococcal Skin Infections - surgery | Adult | Female | Staphylococcal Infections - microbiology | Methicillin Resistance | Pregnancy Complications, Infectious - microbiology | Child | Carrier State | Infant, Newborn | Staphylococcal Infections - drug therapy | Staphylococcal Skin Infections - epidemiology | Comorbidity | Pregnancy Complications, Infectious - epidemiology | Combined Modality Therapy | Staphylococcus aureus - pathogenicity | Drainage | Pregnancy | Staphylococcal Infections - epidemiology | Adolescent | Staphylococcal Infections - prevention & control | Community-Acquired Infections - prevention & control | Staphylococcus aureus - drug effects | Community-Acquired Infections - microbiology | Staphylococcus aureus
Journal Article
Expert Review of Anti-infective Therapy, ISSN 1478-7210, 11/2010, Volume 8, Issue 11, pp. 1293 - 1305
Journal Article
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 07/2013, Volume 68, Issue 2, pp. ii45 - ii55
Antimicrobial drug resistance is a growing problem in Europe and, even with differences in epidemiology, it is of great concern. The treatment of complicated... 
Complicated skin and soft-tissue infections | Complicated intra-abdominal infections | Non-interventional studies | Broad-spectrum antibacterial therapy | Polymicrobial infections | INFECTIOUS DISEASES | non-interventional studies | complicated skin and soft-tissue infections | ESCHERICHIA-COLI | MICROBIOLOGY | broad-spectrum antibacterial therapy | IN-VITRO SUSCEPTIBILITY | polymicrobial infections | complicated intra-abdominal infections | SEVERELY ILL PATIENTS | METALLO-BETA-LACTAMASE | SKIN-STRUCTURE INFECTIONS | INTENSIVE-CARE-UNIT | COMPLICATED INTRAABDOMINAL INFECTIONS | PHARMACOLOGY & PHARMACY | STAPHYLOCOCCUS-AUREUS | BLOOD-STREAM INFECTIONS | KLEBSIELLA-PNEUMONIAE | Skin Diseases, Bacterial - microbiology | Gram-Positive Bacteria - drug effects | Minocycline - pharmacology | Humans | Middle Aged | Minocycline - analogs & derivatives | Drug Resistance, Bacterial | Male | Skin Diseases, Bacterial - drug therapy | Gram-Negative Bacteria - isolation & purification | Anti-Bacterial Agents - therapeutic use | Skin Diseases, Bacterial - epidemiology | Minocycline - therapeutic use | Aged, 80 and over | Adult | Female | Soft Tissue Infections - drug therapy | Bacterial Infections - microbiology | Bacterial Infections - drug therapy | Intraabdominal Infections - microbiology | Europe | Treatment Outcome | Soft Tissue Infections - epidemiology | Intraabdominal Infections - epidemiology | Gram-Negative Bacteria - drug effects | Drug Therapy, Combination - methods | Soft Tissue Infections - microbiology | Bacterial Infections - epidemiology | Gram-Positive Bacteria - isolation & purification | Aged | Anti-Bacterial Agents - pharmacology | Intraabdominal Infections - drug therapy
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 02/2011, Volume 52, Issue 3, pp. e18 - e55
Journal Article